Baynes Roy D. bought TVTX
May 19, 2026 · Form 4 insider transaction
Baynes Roy D. bought 4,000 shares of Travere Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,000
Price
$0.00
Total value
N/A
InsiderBaynes Roy D.
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 19, 2026
Filing dateMay 21, 2026
Shares owned after41,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.; The equity award vests over a one year period.